Final overall survival (OS) analysis of a multicenter phase II study of concurrent high-dose (72Gy) three-dimensional conformal radiotherapy (3D-RT) without elective nodal irradiation with chemotherapy using cisplatin (CDDP) and vinorelbine (VNR) in patients with stage III non-small cell lung cancer (NSCLC).

Hidehito Horinouchi, Yuichiro Ohe, Minako Sumi et al.|Journal of Clinical Oncology|2015

Cited by 0